Small improvement seen in teenager with vCJDBMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7418.765-a (Published 02 October 2003) Cite this as: BMJ 2003;327:765
- Susan Mayor
Neurologists have expressed cautious optimism about small improvements and lack of toxicity in a UK teenager with variant Creutzfeldt-Jakob disease (vCJD) treated with an experimental drug, pentosan polysulphate.
The patient, 19 year old Jonathan Simms …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial